Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED

NCT05727878 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

103

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Persistent Corneal Epithelial Defect

Interventions

DRUG: KPI-012
DRUG: KPI-012 Vehicle

Sponsor

Combangio, Inc

Collaborators

[object Object]